The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry

por Montrose, Kristopher, Yang, Yi, Krissansen, Geoffrey W.
Publicado 2014

mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446

por Bell, Glenn D., Yang, Yi, Leung, Euphemia, Krissansen, Geoffrey W.
Publicado 2018

Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs

por Montrose, Kristopher, Yang, Yi, Sun, Xueying, Wiles, Siouxsie, Krissansen, Geoffrey W.
Publicado 2013

“Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice

por Sun, Xueying, Jiang, Ruohan, Przepiorski, Aneta, Reddy, Shiva, Palmano, Kate P, Krissansen, Geoffrey W
Publicado 2012

A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy

por Cheung, Chun Hei Antonio, Sun, Xueying, Kanwar, Jagat R, Bai, Ji-Zhong, Cheng, LiTing, Krissansen, Geoffrey W
Publicado 2010

Correction: A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy

por Cheung, Chun Hei Antonio, Sun, Xueying, Kanwar, Jagat R, Bai, Ji-Zhong, Cheng, LiTing, Krissansen, Geoffrey W
Publicado 2010

Repositioning drugs for inflammatory disease – fishing for new anti-inflammatory agents

por Hall, Christopher J., Wicker, Sophie M., Chien, An-Tzu, Tromp, Alisha, Lawrence, Lisa M., Sun, Xueying, Krissansen, Geoffrey W., Crosier, Kathryn E., Crosier, Philip S.
Publicado 2014